M. Muhtarov

ORCID: 0000-0002-9426-1791
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Parasitic infections in humans and animals
  • Congenital Anomalies and Fetal Surgery
  • Amoebic Infections and Treatments
  • Toxoplasma gondii Research Studies
  • Zoonotic diseases and public health
  • Parasitic Infections and Diagnostics
  • Parasite Biology and Host Interactions
  • Pelvic floor disorders treatments
  • Parasites and Host Interactions
  • Colorectal Cancer Surgical Treatments
  • Anorectal Disease Treatments and Outcomes

Municipality of Kardzhali
2018-2020

National Center of Infectious and Parasitic Diseases
2016-2017

World Health Organization - Italy
2016

University of Pavia
2016

Queen Giovanna Hospital
2002

Cystic (CE) and alveolar (AE) echinococcosis are chronic, neglected parasitic diseases burdened by high morbidity and, for AE, mortality, if left untreated. CE AE have a widespread distribution, including Europe. Albendazole (ABZ), broad-spectrum benzimidazole drug widely used to treat infections, is the of choice management parasitostatic on echinococcal metacestodes. In Europe, ABZ licensed interrupted "cyclic" treatment, maximum 3 cycles. However, better efficacy with no increased side...

10.1371/journal.pntd.0008566 article EN cc-by PLoS neglected tropical diseases 2020-09-17

Cystic echinococcosis (CE) is a clinically complex chronic parasitic disease, management options for which include surgery, percutaneous treatments, and treatment with albendazole (ABZ) active cysts, the “Watch-and-Wait” approach uncomplicated, inactive cysts. We examined, retrospectively, clinical of 334 patients hepatic CE from southeastern Rhodope region Bulgaria between 2004 2013. Cysts were reclassified according to World Health Organization Informal Working Group on Echinococcosis...

10.4269/ajtmh.15-0620 article EN American Journal of Tropical Medicine and Hygiene 2016-02-02

Aim: To assess the efficacy and patient compliance of topical mononitrate hydrogel for treatment anal fissure. Materials methods: Nineteen patients with symptomatic chronic fissures were randomly allocated to receive either active (10 patients) or placebo (nine gel treatment. Rectal administration containing 0.2% isosorbide‐5‐mononitrate was prescribed. Patients instructed on its application canal twice daily 3 weeks. A questionnaire used determine therapy. Anal manometry performed before...

10.1046/j.1365-2036.2002.01145.x article EN Alimentary Pharmacology & Therapeutics 2002-01-07
Coming Soon ...